These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 202479

  • 1. Serum activity inhibiting specific simian virus 40-induced transplantation resistance and its correlation with primary SV40 tumors appearance in hamsters.
    Volpe EA.
    Experientia; 1978 Jan 15; 34(1):113-6. PubMed ID: 202479
    [Abstract] [Full Text] [Related]

  • 2. In vivo blocking of SV40 virus-induced antitumor resistance by Syrian hamster sera from early stages of primary SV40 carcinogenesis.
    Volpe EA.
    Neoplasma; 1976 Jan 15; 23(4):345-53. PubMed ID: 187966
    [Abstract] [Full Text] [Related]

  • 3. Differences in the capacity of simian virus 40 (SV40) tumor antigens on cells, membranes and in soluble form to induce transplantation immunity in hamsters and mice.
    Law LW, Takemoto KK, Rogers MJ, Henriksen O, Ting RC.
    Int J Cancer; 1978 Sep 15; 22(3):315-22. PubMed ID: 212373
    [Abstract] [Full Text] [Related]

  • 4. Influence of BCG vaccination on the primary and transplantable hamster tumors induced by SV40 and on the specific SV40 virus-induced antitumor immunity.
    Zhalgasbayeva GT.
    Neoplasma; 1976 Sep 15; 23(2):129-36. PubMed ID: 180441
    [Abstract] [Full Text] [Related]

  • 5. Prevention of SV40 virus oncogenesis in hamsters. II. The effect of thymectomy on induction of tumor resistance by SV40-transformed human cells.
    Girardi AJ, Roosa RA.
    J Immunol; 1967 Dec 15; 99(6):1217-20. PubMed ID: 4294651
    [No Abstract] [Full Text] [Related]

  • 6. SV40 tumor rejection induced by vesicular stomatitis virus bearing SV40 tumor-specific transplantation antigen (SV40-TSTA). I. Specificity of immunoprotection and effect of enzyme treatment on TSTA activity.
    Ansel S, Huet C, Tournier P.
    Int J Cancer; 1977 Jul 15; 20(1):51-60. PubMed ID: 71274
    [Abstract] [Full Text] [Related]

  • 7. Induction of simian virus 40 transplantation immunity in hamsters by gel-purified SV40 large T antigen.
    Haddada H, Le Goffic N, Chandrasekaran K, de Vaux Saint Cyr C.
    Immunol Lett; 1988 Jul 15; 18(3):225-9. PubMed ID: 2844659
    [Abstract] [Full Text] [Related]

  • 8. Oncogenicity in newborn and adult Syrian hamsters of SV40 temperature-sensitive (ts) mutants.
    Deichman G, Kashkina L, Rapp F.
    Neoplasma; 1979 Jul 15; 26(1):49-56. PubMed ID: 219381
    [Abstract] [Full Text] [Related]

  • 9. Failure to induce transplantation immunity to an SV40-induced tumour in hamsters immunized with basic proteins of myelin or malignant tissues.
    Flavell DJ, Potter CW.
    Br J Cancer; 1978 Jul 15; 38(1):151-3. PubMed ID: 80222
    [No Abstract] [Full Text] [Related]

  • 10. Tumor induction in newborn and adult Syrian hamsters infected with SV40 temperature-sensitive mutants.
    Deichman G, Kashkina L, Rapp F.
    Intervirology; 1978 Jul 15; 10(2):120-4. PubMed ID: 208997
    [Abstract] [Full Text] [Related]

  • 11. [Prevention of tumor growth by immunization of hamsters with x-irradiated SV40-transformed cells].
    Ashkenazi A, Zadik Z.
    Harefuah; 1969 Nov 02; 77(9):376-9. PubMed ID: 4320099
    [No Abstract] [Full Text] [Related]

  • 12. Variations in the levels of IgG1 and IgG2 subclasses in the sera of normal, immunized and tumor-bearing hamsters.
    Haddada MH, Escribano MJ, De Vaux Saint Cyr C, Barra Y.
    Eur J Cancer Clin Oncol; 1984 Apr 02; 20(4):553-60. PubMed ID: 6539207
    [Abstract] [Full Text] [Related]

  • 13. Prevention and interruption of SV40 induced transplantation immunity with tumor cell extracts.
    Tevethia SS, Rapp F.
    Proc Soc Exp Biol Med; 1966 Nov 02; 123(2):612-5. PubMed ID: 4288641
    [No Abstract] [Full Text] [Related]

  • 14. In vitro induction of tumor-specific immunity by highly purified VSV grown in SV40-transformed cells and tumor glycolipids incorporated into liposomes.
    Ansel S.
    Int J Cancer; 1983 Jun 15; 31(6):785-90. PubMed ID: 6190766
    [Abstract] [Full Text] [Related]

  • 15. Induction of tumor-specific transplantation immunity in hamsters with cell fractions from adenovirus and SV40 tumor cells.
    Coggin JH, Elrod LH, Ambrose KR, Anderson NG.
    Proc Soc Exp Biol Med; 1969 Oct 15; 132(1):328-36. PubMed ID: 4310176
    [No Abstract] [Full Text] [Related]

  • 16. Investigations on the presence of papova virus in certain forms of human cancer. Note 2. Brain tumors.
    Stoian M, Suru M, Hozoc M, Iosipenco M, Athanasiu P, Nastac E, Arseni C, Alexianu D.
    Virologie; 1984 Oct 15; 35(2):127-32. PubMed ID: 6330973
    [Abstract] [Full Text] [Related]

  • 17. [Immunization of hamsters against tumors induced by the SV40 virus].
    Ciobanu Z, Fenyves A.
    Arch Roum Pathol Exp Microbiol; 1970 Oct 15; 29(1):109-16. PubMed ID: 4328000
    [No Abstract] [Full Text] [Related]

  • 18. Demonstration of oncogenic potential of mammalian cells transformed by DNA-containing viruses following photodynamic inactivation.
    Li JL, Jerkofsky MA, Rapp F.
    Int J Cancer; 1975 Feb 15; 15(2):190-202. PubMed ID: 165153
    [Abstract] [Full Text] [Related]

  • 19. Prevention of SV40 virus oncogenesis in hamsters. I. Tumor resistance induced by human cells transformed by SV40.
    Girardi AJ.
    Proc Natl Acad Sci U S A; 1965 Aug 15; 54(2):445-51. PubMed ID: 4285932
    [No Abstract] [Full Text] [Related]

  • 20. Reproducibility and relation to specific and non-specific anti-tumor resistance of the tumor "sneaking through" phenomenon.
    Deichman GI, Kluchareva TE, Kashkina LM, Matveeva VA.
    Int J Cancer; 1979 Apr 15; 23(4):571-84. PubMed ID: 220202
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.